Opioids are important tools for pain management, but abuse can result in serious health complications. Of these complications, respiratory depression that leads to brain hypoxia is the most dangerous, resulting in coma and death. Although all opioids at large doses induce brain hypoxia, danger is magnified with synthetic opioids such as fentanyl and structurally similar analogs. These drugs are highly potent, act rapidly, and are often not effectively treated by naloxone, the standard of care for opioid-induced respiratory depression. The goal of this review paper is to present and discuss brain oxygen responses induced by opioids, focusing on heroin and fentanyl. In contrast to studying drug-induced changes in respiratory activity, we used chronically implanted oxygen sensors coupled with high-speed amperometry to directly evaluate physiological and drug-induced fluctuations in brain oxygen levels in awake, freely moving rats. First, we provide an overview of brain oxygen responses to physiological stimuli and discuss the mechanisms regulating oxygen entry into brain tissue. Next, we present data on brain oxygen responses induced by heroin and fentanyl and review underlying mechanisms. These data allowed us to compare the effects of these drugs on brain oxygen in terms of their potency, time-dependent response pattern, and potentially lethal effect at high doses. Then, we present the interactive effects of opioids during polysubstance use (alcohol, ketamine, xylazine) on brain oxygenation. Finally, we consider factors that affect the therapeutic potential of naloxone, focusing on dosage, timing of drug delivery, and contamination of opioids by other neuroactive drugs. The latter issue is considered chiefly with respect to xylazine, which strongly potentiates the hypoxic effects of heroin and fentanyl. Although this work was done in rats, the data are human relevant and will aid in addressing the alarming rise in lethality associated with opioid misuse.

Introduction: Hypoventilation and hypercapnia are the primary physiological indicators of opioid-induced respiratory depression (OIRD), while hypoxia is typically a later manifestation. However, use of pulse oximetry to measure oxygen saturation (SpO₂) level remains the most widely available and commonly used monitoring modality in both clinical and community settings, whereas capnography is not routinely accessible. Given this reality, it is important to evaluate hypoxia thresholds reported in the literature to inform practical detection and intervention strategies. Oxygen saturation monitoring may serve as a valuable support tool to help determine when individuals experiencing opioid toxicity require intervention; however, there is limited consensus on SpO₂ thresholds that indicate OIRD. Our objective in this study was to evaluate existing evidence on SpO₂ thresholds for OIRD as a physiological marker to incorporate with clinical assessment to potentially prevent opioid-related outcomes such as hypoxemia, hypoxic brain injury, cardiac arrhythmias, and mortality, and to inform monitoring and intervention strategies for future research. Methods: We electronically searched Ovid MEDLINE, Ovid Embase, PubMed, and grey literature databases for qualitative and quantitative studies published from 2014–2024. We included studies published in English where participants with opioid use disorder (OUD) experienced opioid toxicity and continuous SpO₂ monitoring in medical settings. Quality was evaluated using the modified Downs and Black checklist. The primary outcome measure was the SpO₂ level used to quantify opioid-induced respiratory depression. Results: Of the 2,864 articles screened, 37 underwent full-text review, and 16 were included in data extraction and analysis (total patients, N = 12,887). Reported SpO₂ thresholds ranged from 85–95% (median 92, interquartile range 90–95). In three studies where patients experienced opioid-induced respiratory depression, SpO₂ levels dropped to a median value of 80%. Conclusion: Although hypoxia is a late indicator of opioid-induced respiratory depression, SpO₂ monitoring remains a widely deployed tool for detecting clinically significant deterioration. Reported SpO₂ thresholds for defining OIRD ranged from 90-95% across studies of “excellent” and “good” quality, underscoring the need for standardized, patient-centered thresholds to guide monitoring and intervention in future research.

The linear relation of cerebral blood flow to arterial oxygen saturation in hypoxic hypoxia induced with nitrous oxide or nitrogen. This study has demonstrated a linear relationship between cerebral blood flow and arterial oxygen saturation (Sao2) in the cerebral blood flow response in the hypoxic range of Pao2 values, which we believe is documented for the first time. The cerebral blood flow increased 1.02 per cent for each percentage decrease in Sao2 in hypoxia induced with nitrogen. Hypoxia induced with nitrous oxide increased cerebral blood flow at the rate of 2.09 per cent for each one per cent decrease in Sao2 which was dramatically more than the increase associated with hypoxia induced with nitrogen. Increased survival rates at lower Sao2 levels suggested that nitrous oxide also exerts a protective effect on dog myocardium. The mechanism by which hypoxia increases cerebral blood flow is unclear but the prevalent theory is one of neurogenic control which causes cerebral blood flow to increase as the intracellular hydrogen ion ([H+]I) increases in the progressive lactacidosis of hypoxia.

Determinants of the ventilatory responses to hypoxia during sleep. Disagreement exists on the effect of sleep on hypoxic ventilatory responses. We hypothesized that these differences were due to variabilities in methodology of inducing hypoxia, specifically, as they pertained to the PCO2 level during the studies. We therefore measured ventilatory responses to hypoxia with (eucapnic) and without (hypocapnic) added CO2 during wakefulness and sleep in 7 goats. Eucapnic responses to hypoxia were significantly decreased during both slow wave (SWS) and REM sleep. This decrease was not apparent when hypocapnia was allowed to occur. In 4 goats also provided with electromagnetic flow probes for brain blood flow (BBF) measurements, hypocapnia significantly attenuated the increase in BBF induced by hypoxia during both the awake and SWS stages. Concomitantly measured cerebral venous blood also showed lower oxygen tension during hypocapnia. We postulate that under hypocapnic conditions, the depressant effects of brain hypoxia may contribute to the obscuring of differences in hypoxic responses during wakefulness and sleep. Published in The American review of respiratory disease (1984)